Form 4: BioLargo Director Jack B. Strommen Receives Options for Board Service

Director Jack B. Strommen receives options to purchase common stock in BioLargo, Inc. as compensation for board service.

Summary

• On June 30, 2024, BioLargo, Inc. issued an option to purchase 58,824 shares of common stock to Director Jack B. Strommen.
• The options were granted as payment for $15,000 in fees for Strommen's service on the board of directors for the most recent quarterly period.
• The exercise price of the options is $0.255 per share.
• The options were granted pursuant to the Issuer's 2024 Equity Incentive Plan.
• Following the transaction, Strommen directly owns 1,917,151 shares of BioLargo, Inc.
• Jack B. Strommen has granted John R. Browning power of attorney for Section 16 reporting obligations.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to director compensation. There are no explicit positive or negative implications for the company's financial health or future prospects.

Positives

• The issuance of options aligns the director's interests with those of the shareholders.
• The options serve as compensation for board service, conserving cash.

Future Outlook

The document does not contain specific forward-looking statements, but the grant of options suggests continued board service from Jack B. Strommen.

Industry Context

Option grants to directors are a common practice in publicly traded companies to align their interests with shareholders and incentivize performance. This is a standard form filing related to such a grant.

Comparison to Industry Standards

• Option grants to board members are a common practice across various industries.
• The size of the grant (58,824 shares) and the exercise price ($0.255) would need to be compared to similar companies in the environmental technology sector to assess its relative value.
• Companies like Xylem, Inc. or Danaher Corporation, though much larger, also utilize equity compensation for their board members.

Related Party Transactions

• The grant of options to Jack B. Strommen, a director, is a related party transaction.

Stakeholder Impact

• The option grant could potentially dilute existing shareholders if the options are exercised.
• The grant incentivizes the director to act in the best interests of the company and its shareholders.

Key Dates